How does alemtuzumab compare with interferon beta 1a in people with relapsing-remitting multiple sclerosis?
1997 ◽
Vol 103
(1)
◽
pp. 99
2013 ◽
Vol 115
◽
pp. S65-S69
◽
2007 ◽
Vol 254
(12)
◽
pp. 1723-1728
◽
1999 ◽
Vol 67
(4)
◽
pp. 451-456
◽